Astute Analytica publishes a research report on the Asia Pacific In-Vitro Diagnostics Market. The analysis report contains in-depth data about demand, growth, opportunities, challenges, and restraints. In addition, it provides a thorough examination of the structure and possibility of global and regional industries.
Asia Pacific in-vitro Diagnostics Market is projected to reach US$ 23.01 billion by 2031, up from US$ 15.5 billion by 2022, growing at a CAGR of 4.67% from 2023-2031. It analyses the market’s regional trends, size, expansion prospects, and important factors in each region. Additionally, it acknowledges the impact of COVID-19, including updates on the Omicron mutation study, on the market. Both the direct and indirect effects of the pandemic on related industries are taken into account and discussed in the report.
The report gives a thorough analysis of the Asia Pacific In-Vitro Diagnostics Market, covering regional trends, market size, prospects for expansion, and important market factors in each region. In 2021, the United States Gross Domestic Product (GDP) value was US$ 23,315.08 billion, according to verified data from the World Bank. In terms of GDP, the United States accounts for 10.41% of the global economy. The mixed economy of the United States is very advanced. By nominal GDP, it has the largest economy in the world, and by purchasing power parity (PPP), it is second only to China in size.
The leading companies mentioned are
- Abbott
- Agilent Technologies, Inc.
- Becton Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories, Inc
- Charles River Laboratories
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Qiagen
- Quest Diagnostics
- Quidel Corp.
- Siemens Healthineers
- Sysmex Corp.
- Other Prominent Players
The report also acknowledges the impact of COVID-19, including updates on the Omicron mutation study, on the market. It considers both the direct impact of the pandemic and the indirect influence on related industries. The observations on the pandemic’s impact are included in the report.
Furthermore, the report divides geographical regions into several major categories for production, consumption, revenue (in US dollars), and market share analysis. It discusses the predicted growth of the market in these regions between 2021 and 2031.
The segmentation overview of the Asia Pacific In-Vitro Diagnostics Market includes
By Product & Services
- Reagents
- Instruments
- Software
- Services
By Technique
- Immunodiagnostics
- Hematology
- Molecular Diagnostics
- Tissue Diagnostics
- Clinical Chemistry
- Others
By Application
- Cancer diagnostics
- Blood glucose monitoring
- Human genetic testing
- Immunoassays
- Hepatitis tests
- Infectious Diseases diagnostics
- Cardiac Diseases
- Nephrological Diseases
- Gastrointestinal Diseases
- Others
By End-User
- Standalone Laboratories
- Hospitals
- Academic And Medical Schools
- Point Of Care
- Others
By Country
- India
- Japan
- South Korea
- Australia & New Zealand
- ASEAN
- Rest of Asia Pacific